Cross-linking of IgGs bound on circulating neutrophils leads to an activation of endothelial cells: Possible role of rheumatoid factors in rheumatoid arthritis-associated vascular dysfunction

Journal of Inflammation (United Kingdom)

Volumn 10, Issue 1, 2013, Pages

  Rollet Labelle, Emmanuelle ^a   Vaillancourt, Myriam ^a   Marois, Louis ^a   Newkirk, Marianna M ^c   Poubelle, Patrice E ^b   Naccache, Paul H ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Endothelial cells; Fc Rs; Human neutrophils; Rheumatoid factors; Vascular damage

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LYSOZYME; RHEUMATOID FACTOR; SUPEROXIDE;

ARTICLE; BLOOD VESSEL INJURY; CALCIUM CELL LEVEL; CELL ADHESION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; NEUTROPHIL; NEUTROPHIL COUNT; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE STUDY; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR DISEASE;

EID: 84881149451     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-10-27     Document Type: Article

References (63)

1. Vasculitis in rheumatoid arthritis. Turesson C, Matteson EL, Curr Opin Rheumatol 2009 21 35 40 10.1097/BOR.0b013e32831c5303 19077716
2. Vasculitis associated with connective tissue disorders. Doyle MK, Curr Rheumatol Rep 2006 8 312 316 10.1007/s11926-006-0015-5 16839511 (Pubitemid 44623961)
3. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, Matteson EL, Arthritis Rheum 2003 48 54 58 10.1002/art.10705 12528103 (Pubitemid 36091647)
4. Atherogenesis in rheumatoid arthritis: the "rheumatoid vasculopathy"? Fietta P, Delsante G, Acta Biomed 2009 80 177 186 20578409
5. Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms. Moreland LW, Curtis JR, Semin Arthritis Rheum 2009 39 132 143 10.1016/j.semarthrit.2008.08.003 19022481
6. Endothelial dysfunction in rheumatic autoimmune diseases. Murdaca G, Colombo BM, Cagnati P, Gulli R, Spanò F, Puppo F, Atherosclerosis 2012 224 309 317 10.1016/j.atherosclerosis.2012.05.013 22673743
7. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. Song YW, Kang EH, QJM 2010 103 139 146 10.1093/qjmed/hcp165 19926660
8. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Svensson L, Jirholt J, Holmdahl R, Jansson L, Clin Exp Immunol 1998 111 521 526 10.1046/j.1365-2249.1998.00529.x 9528892 (Pubitemid 28160894)
9. Serum transfer of collagen-induced arthritis in mice. Stuart J, Dixon FJ, J Exp Med 1983 158 378 392 10.1084/jem.158.2.378 6886622 (Pubitemid 13049395)
10. The structure and origin of rheumatoid factors. Sutton B, Corper A, Bonagura V, Taussig M, Immunol Today 2000 21 177 183 10.1016/S0167-5699(00) 01589-9 10740238 (Pubitemid 30184787)
11. Serum immunoglobulin levels in healthy children and adults. Stoop JW, Zegers BJ, Sander PC, Ballieux RE, Clin Exp Immunol 1969 4 101 112 4182354
12. Mechanisms of inflammation and leukocyte activation. Ali H, Haribabu B, Richardson RM, Snyderman R, Med Clin North Am 1997 81 1 28 10.1016/S0025- 7125(05)70503-4 9012753 (Pubitemid 27043793)
13. Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Tsuboi N, Asano K, Lauterbach M, Mayadas TN, Immunity 2008 28 833 846 10.1016/j.immuni.2008.04. 013 18538590
14. Neutrophils and immunity: challenges and opportunities. Nathan C, Nat Rev Immunol 2006 6 173 182 10.1038/nri1785 16498448 (Pubitemid 43290987)
15. Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Robinson JI, Carr IM, Cooper DL, Rashid LH, Martin SG, Emery P, Isaacs JD, Barton A, Wilson AG, Barrett JH, Morgan AW, Hum Mutat 2012 33 741 749 10.1002/humu.22031 22290871
16. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, Meinders AE, Breedveld FC, Arthritis Rheum 1997 40 217 225 10.1002/art.1780400206 9041933 (Pubitemid 27114085)
17. The complex role of Fcgamma receptors in the pathology of arthritis. Boross P, Verbeek JS, Springer Semin Immunopathol 2006 28 339 350 10.1007/s00281-006-0049-9 17043867 (Pubitemid 44900573)
18. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Tan Sardjono C, Mottram PL, van de Velde NC, Powell MS, Power D, Slocombe RF, Wicks IP, Campbell IK, McKenzie SE, Brooks M, Stevenson AW, Hogarth PM, Arthritis Rheum 2005 52 3220 3229 10.1002/art.21344 16200626 (Pubitemid 41447105)
19. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. Kleinau S, Martinsson P, Heyman B, J Exp Med 2000 191 1611 1616 10.1084/jem.191.9.1611 10790435 (Pubitemid 30257357)
20. Transgenic mice expressing human FcgammaRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cells. Van de Velde NC, Mottram PL, Powell MS, Lim B, Holmdahl R, Hogarth PM, Immunol Lett 2010 130 82 88 10.1016/j.imlet.2009.12.005 20005897
21. FcgammaRIIa is a target for modulation by TNFalpha in human neutrophils. Belostocki K, Park MS, Redecha PB, Masuda E, Salmon JE, Pricop L, Clin Immunol 2005 117 78 86 10.1016/j.clim.2005.07.001 16084773 (Pubitemid 41725473)
22. Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Mayadas TN, Tsokos GC, Tsuboi N, Circulation 2009 120 2012 2024 10.1161/CIRCULATIONAHA.108.771170 19917895
23. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Baetta R, Corsini A, Atherosclerosis 2010 210 1 13 10.1016/j.atherosclerosis.2009.10.028 19931081
24. Overlapping roles of endothelial selectins and vascular cell adhesion molecule-1 in immune complex-induced leukocyte recruitment in the cremasteric microvasculature. Norman MU, Van De Velde NC, Timoshanko JR, Issekutz A, Hickey MJ, Am J Pathol 2003 163 1491 1503 10.1016/S0002-9440(10)63506-7 14507656 (Pubitemid 37175096)
25. C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment. Stokol T, O'Donnell P, Xiao L, Knight S, Stavrakis G, Botto M, von Andrian UH, Mayadas TN, J Exp Med 2004 200 835 846 10.1084/jem.20040501 15466618 (Pubitemid 39362920)
26. Capture of flowing human neutrophils by immobilised immunoglobulin: roles of Fc-receptors CD16 and CD32. Skilbeck CA, Lu X, Sheikh S, Savage CO, Nash GB, Cell Immunol 2006 241 26 31 10.1016/j.cellimm.2006.07.007 16934243 (Pubitemid 44441165)
27. The paradox of the neutrophil's role in tissue injury. Segel GB, Halterman MW, Lichtman MA, J Leukoc Biol 2011 89 359 372 10.1189/jlb.0910538 21097697
28. Tyrosine phosphorylation in activated human neutrophils -comparison of the effects of different classes of agonists and identification of the signaling pathways involved. Rollet E, Caon AC, Roberge CJ, Liao NW, Malawista SE, McColl SR, Naccache PH, J Immunol 1994 153 353 363 7515926 (Pubitemid 24186549)
29. Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb. van Mirre E, Teeling JL, van der Meer JW, Bleeker WK, Hack CE, J Immunol 2004 173 332 339 15210791 (Pubitemid 38797358)
30. A rapid flow cytometry assay for the assessment of calcium mobilization in human neutrophils in a small volume of lysed whole-blood. Desmeules P, Dufour M, Fernandes MJ, J Immunol Methods 2009 340 154 157 10.1016/j.jim.2008.10.006 19000691
31. Recruitment of the cross-linked opsonic receptor CD32A (FcgammaRIIA) to high-density detergent-resistant membrane domains in human neutrophils. Rollet-Labelle E, Marois S, Barbeau K, Malawista SE, Naccache PH, Biochem J 2004 381 919 928 10.1042/BJ20031808 15130090 (Pubitemid 39120504)
32. CD16b associates with high-density, detergent-resistant membranes in human neutrophils. Fernandes MJ, Rollet-Labelle E, Pare G, Marois S, Tremblay ML, Teillaud JL, Naccache PH, Biochem J 2006 393 351 359 10.1042/BJ20050129 16171455 (Pubitemid 43049332)
33. Signaling through CD16b in human neutrophils involves the Tec family of tyrosine kinases. Fernandes MJ, Lachance G, Pare G, Rollet-Labelle E, Naccache PH, J Leukoc Biol 2005 78 524 532 10.1189/jlb.0804479 15899983 (Pubitemid 41061324)
34. Insoluble and soluble immune complexes activate neutrophils by distinct activation mechanisms: changes in functional responses induced by priming with cytokines. Fossati G, Bucknall RC, Edwards SW, Ann Rheum Dis 2002 61 13 19 10.1136/ard.61.1.13 11779751 (Pubitemid 34074832)
35. Modulation of human neutrophil responses to CD32 cross-linking by serine/threonine phosphatase inhibitors: Cross-talk between serine/threonine and tyrosine phosphorylation. Rollet-Labelle E, Gilbert C, Naccache PH, J Immunol 2000 164 1020 1028 10623852 (Pubitemid 30043730)
36. Fc{gamma}RIIIB stimulation promotes {beta}1 integrin activation in human neutrophils. Ortiz-Stern A, Rosales C, J Leukoc Biol 2005 77 787 799 10.1189/jlb.0504310 15661829 (Pubitemid 40628759)
37. Regulation of stimulated integrin surface expression in human neutrophils by tyrosine phosphorylation. Naccache PH, Jean N, Liao NW, Bator JM, McColl SR, Kubes P, Blood 1994 84 616 624 7912966 (Pubitemid 24215965)
38. Endothelial P2Y2 receptor regulates LPS-induced neutrophil transendothelial migration in vitro. Kukulski F, Ben Yebdri F, Bahrami F, Fausther M, Tremblay A, Sevigny J, Mol Immunol 2010 47 991 999 10.1016/j.molimm.2009.11.020 20022380
39. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Middleton J, Patterson AM, Gardner L, Schmutz C, Ashton BA, Blood 2002 100 3853 3860 10.1182/blood.V100.12.3853 12433694 (Pubitemid 35396849)
40. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A, Valesini G, Ann Rheum Dis 2004 63 1218 1221 10.1136/ard.2003.014647 15361374 (Pubitemid 39273496)
41. Fc{gamma}RIIIb Triggers Raft-dependent Calcium Influx in IgG-mediated Responses in Human Neutrophils. Marois L, Pare G, Vaillancourt M, Rollet-Labelle E, Naccache PH, J Biol Chem 2011 286 3509 3519 10.1074/jbc.M110.169516 21123174
42. Functional separation of pseudopod extension and particle internalization during Fc gamma receptor-mediated phagocytosis. Lowry MB, Duchemin AM, Robinson JM, Anderson CL, J Exp Med 1998 187 161 176 10.1084/jem.187.2.161 9432974 (Pubitemid 28060432)
43. The molecular dissection of Fc gamma receptor mediated phagocytosis. Indik ZK, Park JG, Hunter S, Schreiber AD, Blood 1995 86 4389 4399 8541526
44. Transfection of an Fc gamma receptor cDNA induces T cells to become phagocytic. Hunter S, Kamoun M, Schreiber AD, Proc Nat Acad Sci USA 1994 91 10232 10236 10.1073/pnas.91.21.10232 7937868 (Pubitemid 24311983)
45. Functional capacity of fcgamma receptor-III (CD16) on human neutrophils. Edberg JC, Salmon JE, Kimberly RP, Immunol Res 1992 11 239 251 10.1007/BF02919130 1287118 (Pubitemid 23017173)
46. Modulation of Fcgamma and complement receptor function by the glycosyl-phosphatidylinositol-anchored form of FcgammaRIII. Edberg JC, Kimberly RP, J Immunol 1994 152 5826 5835 8207210
47. Rheumatoid factors: what do they tell us? Newkirk MM, J Rheumatol 2002 29 2034 2040 12375308
48. Rheumatoid factors: good or bad for you? Nowak UM, Newkirk MM, Int Arch Allergy Immunol 2005 138 180 188 10.1159/000088794 16210858 (Pubitemid 41540675)
49. Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis. Jarvis JN, Petty HR, Tang Y, Frank B, Tessier PA, Dozmorov I, Jiang K, Kindzelski A, Chen Y, Cadwell C, Turner M, McGhee JL, Centola M, Arthritis Res Ther 2006 8 154 10.1186/ar2048 17002793
50. Rheumatoid peripheral blood phagocytes are primed for activation but have impaired Fc-mediated generation of reactive oxygen species. Fairhurst AM, Wallace PK, Jawad AS, Goulding NJ, Arthritis Res Ther 2007 9 29 10.1186/ar2144 17355628 (Pubitemid 46534795)
51. Activation of Syk in neutrophils by antineutrophil cytoplasm antibodies occurs via Fcgamma receptors and CD18. Hewins P, Williams JM, Wakelam MJ, Savage CO, J Am Soc Nephrol 2004 15 796 808 10.1097/01.ASN.0000113241.98702.77 14978183 (Pubitemid 38294811)
52. Activation of the G(i) heterotrimeric G protein by ANCA IgG F(ab')2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG. Williams JM, Ben-Smith A, Hewins P, Dove SK, Hughes P, McEwan R, Wakelam MJ, Savage CO, J Am Soc Nephrol 2003 14 661 669 10.1097/01.ASN.0000050223.34749.F4 12595502 (Pubitemid 36246010)
53. Proteolysis induces increased binding affinity of the monocyte type II FcR for human IgG. van de Winkel JG, van Ommen R, Huizinga TW, de Raad MA, Tuijnman WB, Groenen PJ, Capel PJ, Koene RA, Tax WJ, J Immunol 1989 143 571 578 2525588 (Pubitemid 19191554)
54. Cell-specific, activation-dependent regulation of neutrophil CD32A ligand-binding function. Nagarajan S, Venkiteswaran K, Anderson M, Sayed U, Zhu C, Selvaraj P, Blood 2000 95 1069 1077 10648424 (Pubitemid 30062733)
55. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis. Belostocki K, Pricop L, Redecha PB, Aydin A, Leff L, Harrison MJ, Salmon JE, Arthritis Rheum 2008 58 384 388 10.1002/art.23200 18240208 (Pubitemid 351294873)
56. Free radicals and endothelial dysfunction: Potential positive effects of TNF inhibitors. Murdaca G, Spanò F, Cagnati P, Puppo F, Redox Rep 2013 18 95 99 10.1179/1351000213Y.0000000046 23676793
57. Cardiovascular death in rheumatoid arthritis: a population-based study. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE, Arthritis Rheum 2005 52 722 732 10.1002/art.20878 15751097 (Pubitemid 40365093)
58. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Suppiah R, Judge A, Batra R, Flossmann O, Harper L, Hoglund P, Javaid MK, Jayne D, Mukhtyar C, Westman K, Davis JC, Hoffman GS, McCune WJ, Merkel PA, St Clair EW, Seo P, Spiera R, Stone JH, Luqmani R, Arthritis Care Res (Hoboken) 2011 63 588 596 10.1002/acr.20433
59. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Hernandez-Vargas P, Ortiz-Munoz G, Lopez-Franco O, Suzuki Y, Gallego-Delgado J, Sanjuan G, Lazaro A, Lopez-Parra V, Ortega L, Egido J, Gomez-Guerrero C, Circ Res 2006 99 1188 1196 10.1161/01.RES.0000250556. 07796.6c 17053192 (Pubitemid 44808655)
60. Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). Colombo BM, Cacciapaglia F, Puntoni M, Murdaca G, Rossi E, Rodriguez G, Nobili F, Pisciotta L, Bertolini S, Moccetti T, Dentali F, Steidl L, Ciprandi G, Afeltra A, Indiveri F, Puppo F, Autoimmun Rev 2009 8 309 315 10.1016/j.autrev.2008.10.002 18976721
61. Intima-media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus. Colombo BM, Murdaca G, Caiti M, Rodriguez G, Grassia L, Rossi E, Indiveri F, Puppo F, Ann N Y Acad Sci 2007 1108 121 126 10.1196/annals.1422.014 17893978 (Pubitemid 47528725)
62. The ubiquitin ligase c-Cbl down-regulates FcgammaRIIa activation in human neutrophils. Marois L, Vaillancourt M, Marois S, Proulx S, Pare G, Rollet-Labelle E, Naccache PH, J Immunol 2009 182 2374 2384 10.4049/jimmunol. 0801420 19201892
63. CIN85 modulates the downregulation of Fc{gamma}RIIa expression and function by c-CBL in a PKC-dependent manner in human neutrophils. Marois L, Vaillancourt M, Pare G, Gagne V, Fernandes MJ, Rollet-Labelle E, Naccache PH, J Biol Chem 2011 286 15073 15084 10.1074/jbc.M110.213660 21372129